Monoclonal antibody therapy and COVID-19

Credit: PIXTA / CC0 public domain

Monoclonal antibody therapy is an infusion therapy that can reduce the severity of COVID-19. Here are some of the most frequently asked questions about treatment:

Q: What is a monoclonal antibody? How does it work?

A: Monoclonal antibody A protein created in the lab. The protein mimics your immune system and aims to make COVID-19 disease more mild in patients who are already ill.

Q: Who is eligible for treatment?

A: The Food and Drug Administration (FDA) grants an emergency use authorization to allow the use of monoclonal antibody therapy for the treatment of mild to moderate COVID-19 in adult and pediatric patients (12+ and 85+). Was issued. Pounds) People who test positive for COVID-19 and are at high risk for moderate to severe COVID-19.

Q: Why do I need to worry about vaccines when I get COVID and can get antibody treatment?

A: Vaccines have been shown to be very effective in preventing the acquisition of COVID-19 and significantly reduce symptoms when the strain is infected. Monoclonal antibodies are not as effective as vaccines in preventing COVID-19 and cannot be treated until the test is positive. It is also important to receive monoclonal antibody therapy promptly after finding a positive case. Depending on where you live, it can be difficult to schedule treatment and should be considered as the last line of defense to avoid hospitalization for this disease. Finally, monoclonal antibody therapy may not work for everyone. This is another reason to get vaccinated.

NS; The COVID test was positive, but there are no symptoms. Can I get antibody treatment?

A: If you have a positive test result, are 65 years of age or older, or have one of the risk factors for severe COVID-19, such as obesity. Chronic kidney disease, Diabetes, immunosuppressive disease, immunosuppressive treatment, cardiovascular disease, Biting erythrocytosis,pregnancy, Chronic lung disease, Neurodevelopmental disorder Or other conditions that result in medical complexity (eg) Cerebral palsy, Genetic / metabolic syndrome, severe congenital anomalies, or medical-related technical addictions (eg, tracheostomy or gastrostomy), contact the primary care provider for referral for treatment is needed.

Q: Is the treatment effective?

A: Monoclonal antibodies have been shown to be effective, but full FDA approval requires more data. Currently, the drug is only available through an emergency use authorization.

Q: How can I get treatment?

A: Talk to your doctor about monoclonal antibody therapy. Monoclonal antibody therapy requires doctor’s instructions.

Q: How is it managed?

A: The drug can be given intravenously or in four different injections to four different parts of the body. NS Healthcare workers; medical institutions Treatment must be given as it requires an observation period of 1 hour after dosing to ensure that the dosing is well tolerated.

Treatment plans reduce hospitalization and mortality of liver and kidney transplant recipients due to COVID-19

Quote: Monoclonal antibody therapy and COVID-19 (2021, October 19) from https: // on October 19, 2021 Obtained.

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.

Monoclonal antibody therapy and COVID-19

Source link Monoclonal antibody therapy and COVID-19

Show More

Related Articles

Back to top button